$29.570
+1.295 (+4.38%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de RAPP por análisis de gráficos similares
Alphio's RAPP stock price prediction model matches the current Rapport Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $27.86 (+1.04%). The 1-week path is $27.42 (-0.53%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Rapport Therapeutics Inc?
Rapport Therapeutics Inc is a good buy right now due to its current price of $30.65, significantly below the average analyst price target of $65, which suggests a potential upside of over 100%. Additionally, the company has a strong cash position of $436 million, which can support its operations through 2029, despite recent losses. The main risk is the widening net loss reported in Q2 of $56.6 million, which raises concerns about financial sustainability.
RAPP cerró en $29.57 el Thursday, tras subir +4.38%
Rapport Therapeutics Inc (RAPP) last closed at $27.57, losing -6.76%. These facts feed the 1-day and 1-week RAPP price prediction above.
Factores de la previsión
Los factores de la previsión de Rapport Therapeutics Inc (RAPP) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de RAPP, ordenadas por similitud.
Análisis de estacionalidad de RAPP
Historically the probability of a positive October return for RAPP is 86.21%. November offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de RAPP
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $11.59 | $13.51 | $13.94 | -51.00% |
| Nov 2026 | $13.96 | $15.06 | $17.94 | -45.39% |
| Dec 2026 | $13.60 | $15.18 | $17.69 | -44.93% |
En 2026, se proyecta que Rapport Therapeutics Inc (RAPP) oscile entre $11.59 y $17.94.
Previsión mensual de Rapport Therapeutics Inc para 2026
En Oct de 2026, se proyecta que Rapport Therapeutics Inc promedie $13.51, con un mínimo de $11.59 y un máximo de $13.94.
En Nov de 2026, se proyecta que Rapport Therapeutics Inc promedie $15.06, con un mínimo de $13.96 y un máximo de $17.94.
En Dec de 2026, se proyecta que Rapport Therapeutics Inc promedie $15.18, con un mínimo de $13.60 y un máximo de $17.69.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.